Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Deleting Crif1 in mouse skin disrupts skin balance and hair growth.

Calcium blockers may help prevent hearing loss by protecting hair cells.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Stat3 influences keratinocyte stem cell behavior, affecting differentiation and migration.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Researchers discovered how to control Claudin expression in cells, aiding cancer and regenerative medicine research.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

Blocking TRPV3 may help treat itch in dry skin conditions.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Six existing drugs may help block virus entry in COVID-19.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

TCDD exposure causes sebaceous glands to differentiate and produce more lipids before shrinking.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.